KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $236000.0.

  • Bionano Genomics' Amortizatization of Intangibles fell 1060.61% to $236000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $867000.0, marking a year-over-year decrease of 3833.57%. This contributed to the annual value of $1.3 million for FY2024, which is 14415.58% up from last year.
  • As of Q3 2025, Bionano Genomics' Amortizatization of Intangibles stood at $236000.0, which was down 1060.61% from $249000.0 recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Amortizatization of Intangibles peaked at $694000.0 during Q1 2024, and registered a low of -$299000.0 during Q1 2022.
  • In the last 5 years, Bionano Genomics' Amortizatization of Intangibles had a median value of $181000.0 in 2023 and averaged $142062.5.
  • Per our database at Business Quant, Bionano Genomics' Amortizatization of Intangibles crashed by 8267.48% in 2022 and then soared by 74634.15% in 2024.
  • Bionano Genomics' Amortizatization of Intangibles (Quarter) stood at $329000.0 in 2021, then tumbled by 82.67% to $57000.0 in 2022, then soared by 303.51% to $230000.0 in 2023, then tumbled by 39.13% to $140000.0 in 2024, then skyrocketed by 68.57% to $236000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $236000.0 for Q3 2025, versus $249000.0 for Q2 2025 and $242000.0 for Q1 2025.